chrisvoncsefalvay/vaers-outcomes huggingface dataset:
numbness to left side of face approximately 30 minutes after vaccine.. lasted 3 days ( 2/15-2/18)  weakness, fatigue , shortness of breath, used my asthma puffer,  went out for walk with my dogs as I usually do on a mountain path, elevation 5-6,000 ft and broke out in heavy  sweats, and shortness of breath.  these symptoms lasted about 3 days..  I was scheduled for the 2nd moderna covid shot today 3/15/21 but after talking to  the nurses there they advised me to fill out this report and postpone the 2nd shot  until I hear from you,
This is a spontaneous report from a contactable healthcare professional. A 77-year-old female patient received her first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) on her left arm, via an unspecified route of administration on 28Jan2021 13:30 at a single dose for covid-19 immunization.  Medical history included diabetes type 2 and neuropathy (reported as neuropothy). The patient experienced Upper and middle back severe pain, nausea, vomiting, diarrhea; all on 01Feb2021 04:00 AM. The outcome of the events was unknown.  Information on the lot/batch number has been requested.
Vaccine on 6-22-2010, redness and swelling noted upon return to clinic on 6-24-2010.  Sensitive to touch and is painful.
Patient received COVID-19 vaccine (Pfizer) on 3/17/21 and 4/7/21. On 6/22, she required admission to hospital due to SOB. Pt presented with "gradually worsening SOB in last 10 days with frequent wheezing and productive cough of white sputum. She is a former smoker; quit 1 month ago. Desatting to 80s with fever." COVID-19 positive on 6/22; COPD exacerbation also noted. Seen in outpatient pulmonary clinic on 6/14: "Patient is on 1.5 L O2 during the day and 2 L during the night since last year." Hx of ILD. Patient still hospitalized at this time for COPD exacerbation and NSVT. Reporting due as a breakthrough positive case per EUA requirements.
This spontaneous report as received from an other health professional refers to patients of unknown age and gender. Since June 2016, the patients were vaccinated with improperly stored doses of ROTATEQ for prophylaxis reconstituted with sterile diluent. No adverse effects were reported. Data logger was involved. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1709USA001903: US-009507513-1709USA001915: US-009507513-1709USA001916: US-009507513-1709USA001918: US-009507513-1709USA001919.
Multiple seizures that were not common with epilepsy. This occurred for a couple of days after the vaccine.
Narrative: Patient received Moderna Covid vaccine #1 on 3/5/21 and #2 on 4/2/21. There are no notes in system or scanned records from the time of second vaccine to his date of death on 4/25/21 that indicate what happened. Time from second vaccine to date of death is 23 days. No autopsy report is available.
A few months later I started getting vertigo and had to go see an ENT for sudden episode of vertigo that did not fade for several days. My PCP referred me to an ENT who performed and audiology test and determined that I had a viral inflammation. I was prescribed methylprednisolone which helped and symptoms faded. I was fine for a few weeks and my symptoms returned. My doctor referred me to a different ENT who gave me another dose pack of the medication. I was advised that the root cause was either allergy related or related to blood pressure which caused my symptoms to dissolve. I occasionally have ringing in my ears and would say I am 98% recovered.
Received TD, then MMR #2, within 1-2 mins c/o feeling "funny" became unresponsive, eyes rolled back and fixated, became rigid with head hyper extended, gurgling sounds from throat. BP 120/60, pulse80, continuous respirations. Ammonia inhalant applied under nose; rigidity of limbs and head began subsiding. Then followed random involuntary movement of limbs and pt had to be restrained by nurse to prevent injury; she then began responding. Slowly to name and returned to conscious state. c/o head hurting and eyes stinging. She was ambulatory on leaving with mother who transported her to PMD ofice for further eval of reactions.
Information has been received from an investigator concerning a 70 year old male who entered a study, title as stated above. On 7/3/06 the pt was vaccinated SC in the deltoid region of the arm with a .065 ml dose of Varicella Zoster virus vaccine live. On approx 7/10/06, one week after vaccination, the pt was vaccinated with travel immunizations which included Hep A, typhoid vaccine and DPT. It was reported that the pt has been instructed not to receive any other vaccinations within one month of receiving varicella zoster virus vaccine live. About 48 hours after receiving the travel immunization, on 7/12/06, the pt developed vomiting, vertigo and passed out while at home. The vertigo was severe enough of the pt, who is a dentist, to cancel his appointments. The pt reported that he went to his primary physician on 7/17/06 and was determined to have hearing loss. The reporting investigator felt that hearing loss, vomiting and vertigo were possibly related to vaccination with varicella zoster virus vaccine live. Hearing loss, vomiting and vertigo were considered to be other important medical events (OMIC). Additional information has been requested.
Headache  night sweats, ha, fatigue and muffled hearing Narrative  Other Relevant History:
Projectile vomiting, double vision, confusion/ delirium  No treatment just gave her time. All symptoms cleared within 6 hours of onset. Approximately 9 hours after vaccine administration. Other more expected immune response followed, sore arm, headache, body aches and lethargy. Theses all resolved 36 hours after vaccine administration.
My arm was sore at the injection side for 2 day, not severe. This afternoon I had a stomach ache after eating, which by 5:30 progressed to diarrhea, vomiting, stomach pain, fever 101.2, with body aches and chills.
This spontaneous report was received from a nurse practitioner and refers to a 4 year old patient of unknown gender. Information regarding the patient's pertinent medical history, concurrent conditions, concomitant and historical drugs was not provided. The reporter stated that, on 06-SEP-2018, the patient was vaccinated with ROTATEQ, oral, lot # N030476, expiration date 17-JUN-2019 (dose was not reported) for prophylaxis (drug administered to patient of inappropriate age). No adverse effects were reported. Lot number N030476 is an invalid lot number for rotavirus vaccine, live, oral, pentavalent.
This spontaneous report was received from a pharmacist refers to a patient of unknown age and gender. Medical history and concurrent conditions were not reported. On 31-JUL-2014, the patient was vaccinated with ZOSTAVAX (dose number was not reported), 0.65 ml, subcutaneous. Co-suspect and concomitant therapies were not reported. The pharmacist reports that on 31-JUL-2014 a ZOSTAVAX that underwent a temperature excursions was administered to five patients. (MARRS 1408USA006489, 1408USA006490, 1408USA006491, 1408USA006492 AND 1408USA001809). This case is one (1) of five (5) reports from the same source. Additional information has been requested.
No immediate adverse effects.  Very little soreness.  I was told to rub/massage the injection site to reduce any pain or swelling.  Red area, swelling, and itching appeared on the  fourth day following the vaccination.  Current size of area is approx. 12 cm by 6 cm.  The long side of the area runs vertical on my arm.  The  vaccination site is about 1 cm down from the top of the swelling, so the swelling, redness and itching mostly extend down my arm from the injection site
UNKNOWN VACCINATION LOCATION. ADMITTED TO CENTER THE DAY AFTER HIS 2ND SHOT FOR CONFUSION, MENTAL STATUS CHANGES, SYNCOPE VS SEIZURE ACTIVITY, LOSS OF CONSCIOUSNESS. NEURO CONSULTED AND THOUGHT POSSIBLE ADVERSE REACTION TO COVID VACCINE #2 AS NO OTHER REASON HAS BEEN FOUND WITH LABS, IMAGING, ETC. NEURO CALLING IT A 2 HOUR FUGUE EVENT.
Woke up next day, severe stiffness, headache, fever, chills, fatigued. The injection site was red and extremely painful
Patient received Varivax 10/11/00 per old record. (?where or by whom) seen 10/2706 by me (her own pediatrician) with HERPES ZOSTER in L2 distribution.
Moderna COVID-19 Vaccine EUA Red, itchy, hot rash at injection site 9 days after the vaccine was given.
12-7-07 4:00 a.m. awoke with high fever, headache, and nausea. Also soreness in both arms.No changes noted in behavior. 2:30 p.m spoke to mother and they were just leaving the clinic. Continues to have fever 102.3, headache, and nausea. 12-8-07 fever 101 with headache, and nausea. 12-9-07 no fever or headache but little energy. 12-10-07 still at home with nausea and no fever or headache, but paleness.
loss of hearing; Right arm sore; Tinnitus; Fatigue; Muscle aches; Hot and cold; High blood pressure.; This is a spontaneous report from a non-contactable consumer (patient). This female adult patient received bnt162b2 dose 2 via unspecified route of administration in right arm in Mar2021 02:00 PM (Lot number unknown) at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not provided. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient previously received bnt162b2 dose 1 via unspecified route of administration in right arm in Feb2021 02:00 PM (Lot number unknown) at single dose for COVID-19 immunization and experienced right arm sore. The patient received the second dose in Mar2021 and experienced loss of hearing, right arm sore, tinnitus, fatigue, muscle aches, hot and cold, high blood pressure on 08Mar2021 17:00. The events resulted in Doctor or other healthcare professional office/clinic visit and Emergency room/department or urgent care. The patient received Injection of steroid for ear as treatment. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the event events was recovered.   Information on the lot/batch number has been requested.
p/ pt recv varivax 4/14 the following day pt devel a ``urticarial, red, rash & blanching, blotchy, pruritic rash'' treated w/diphenhydramine for itching.
Patient received vaccine at approximately 11:00am. Daughter reported he called her at approximately 2:45pm complaining of shortness of breath. She called niece (a 911 operator). Pt. was taken to hospital, had respiratory arrest. Was intubated 7 days. Hospitalized 10 days. Spent 1 month in rehab facility.
Child found apneic, unresponsive, brought to hospital by EMS with CPR in progress, child expired.
On July 24, 2021 I came down with what looked to be a rash  with sores on right arm and back right shoulder.  The shoulder started having extreme pain, which radiated down my arm and into my right thumb.  Went to a clinic on July 26, 2021 and they diagnosed it as shingles.  I had received a shingles vaccination on 11/13/2015.  I continued to have pain on my right arm and it eventually settled in my right thumb.  The thumb had sores break out all over the knuckle and the fingernail turned black as if it had been hit.  The thumb is still numb, as if it is asleep.  The nurse stated that they had seen other cases of shingles in people who had been vaccinated with the moderna vaccine.
This case was reported by a other health professional via sales rep and described the occurrence of injection site swelling in a patient who received BEXSERO. On an unknown date, the patient received BEXSERO .5 ml. On an unknown date, an unknown time after receiving BEXSERO, the patient experienced injection site swelling. On an unknown date, the outcome of the injection site swelling was unknown. It was unknown if the reporter considered the injection site swelling to be related to BEXSERO. Additional details were received as follows: Medical Science Liaison indicated that an office manager contacted her to report that a female patient (not much info known), no lot, no expiration date, no vaccination date, or age of the patient was vaccinated with BEXSERO, and then the next morning, could not get up, was lethargic and tired for two days; pain at the injection site; stayed home from school for two days (see case US2016046410). Office manager then mentioned that another patient concerned in this case who received also BEXSERO and experienced a softball-like swelling at the injection site. Also mentioned about some other patients (see case US2016GSK049201) who also received a dose of BEXSERO vaccine and felt tired and lethargic for about two days, then the symptoms were resolved. The office manager indicated that she would be happy to be contacted by GSK for more information gathering if needed.
Chills; hot; Myalgia; This is a spontaneous report from a contactable physician.  A 73-years-old female patient received second dose of bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Batch number: Not reported/Lot Number: EN6201), via intramuscular route of administration, administered in Arm Left on 16Feb2021 (Age at vaccination 73-years-old), as dose 2, single for covid-19 immunization. Medical history included anxiety and increased cholesterol from an unknown date and unknown if ongoing. Concomitant medications included calcium, melatonin, diphenhydramine hydrochloride, paracetamol (TYLENOL PM) taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines around the time of Pfizer-BioNTech COVID-19 vaccine vaccination. The patient previously received first dose of bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Batch number: Not reported/Lot Number: EL3302), via intramuscular route of administration, administered in Arm Left on 26Jan2021 (Age at vaccination 73-years-old), as DOSE 1, SINGLE for covid-19 immunization and experienced cough, shortness of breath and swelling which resolved in 10-15 minutes. The patient did not require medical intervention, emergency department visit, hospitalization. Patient was not admitted to an intensive care unit as a result of signs and symptoms of the anaphylactic reaction. There was not an organ involvement such as multiorgan involvement, Stridor, Upper airway swelling, Respiratory distress, Tachypnoea, Increased use of accessory respiratory muscles, Recession, Cyanosis, Grunting, Hoarse voice, Difficulty breathing (without wheeze or stridor), Sensation of throat closure, Sneezing, Rhinorrhea, Cardiovascular, Dermatological/mucosal, Generalized urticarcia, Generalized erythema, Angioedema (not hereditary), Generalized pruritus with skin rash, Generalized pruritus without skin rash, Generalized prickle sensation, Red and itchy eyes, Gastrointestinal. As a result of the events patient did not require the initiation of new medication or other treatment or procedure. Outcome following the potential anaphylactic reaction was recovered those were not anaphylactic. There were no laboratory tests or diagnostic studies performed. On an unspecified day and month of 2021, the patient experienced chills, hot and myalgia. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events was recovered on unknown date.  No follow-up attempts are needed. No further information is expected.
Patient received the immunization on 9/12/2023,  she could not give an exact date when the symptoms started.  Her symptoms began with what she described as red hives looking like little bug bites around the area of the injection.  Today, 9/19/2023, all redness has resolved and the arm is only puffy.  She stated that there were no signs of puss nor an abcess.
I received my vaccine while I was pregnant and did not know it, both doses. I have now had my baby at 29 weeks, and wanted to report what is going on.
pain, redness, swelling to left upper arm  2 smaller round lesions approx 1 cm in the center of the larger reg swollen area.  Tried zytec, ibuprofen and ice.  given Keflex to start on 4/25/19
Hospitalization for acute pancreatitis (incidental COVID-19) on dates 1/28/2023- 2/1/2023. Treated with no COVID-19 medications.
Approximately 30 minutes after injection patient presented to the emergency department with mild facial swelling. Both cheeks and around her lips feel a little swollen.  Denies trouble breathing or swelling in her tongue or intraoral area.   Patient treated with diphenhydramine, prednisone and famotidine.  Symptoms resolved.
myocarditis; chest pains; racing heart; pounding; This is a spontaneous report received from a contactable reporter(s) (Pharmacist) from medical information team for a Pfizer sponsored program (005570). The reporter is the patient.  A 36 year-old male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunization more than 6 months ago. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose number: 1), for COVID-19 immunization. The following information was reported: MYOCARDITIS (medically significant) with onset 2021, outcome "unknown", described as "myocarditis"; CHEST PAIN (non-serious) with onset 2021, outcome "recovered", described as "chest pains"; HEADACHE (non-serious) with onset 2021, outcome "recovered", described as "pounding"; HEART RATE INCREASED (non-serious) with onset 2021, outcome "recovered", described as "racing heart". About 14 hours after receiving the second dose, the patient developed chest pains and a pounding, racing heart. It resolved by the next day, so the patient never sought medical care. His symptoms and their presentation seem consistent with myocarditis. What was Pfizer's recommendation for someone seeking a booster shot that had myocarditis after the second shot.  The patient underwent the following laboratory tests and procedures: heart rate: (2021) racing heart. The lot number for bnt162b2 was not provided and will be requested during follow up.; Sender's Comments: There is not a reasonable possibility that reported myocarditis, chest pain and Heart rate increased are related to BNT162B2.   The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
infected with tuberculosis; Shortness of breath; she was sick; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 21-year-old female patient received BNT162b2 (BNT162B2), on 16Apr2021 as dose 1, single (Batch/Lot number: unknown) at the age of 20 years, in left arm for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: DYSPNOEA (caused and prolonged hospitalization) with onset 2021, outcome "unknown", described as "Shortness of breath"; TUBERCULOSIS (caused and prolonged hospitalization, medically significant) with onset 2021, outcome "unknown", described as "infected with tuberculosis"; ILLNESS (non-serious), outcome "unknown", described as "she was sick". The patient was hospitalized and prolonged hospitalization for tuberculosis, dyspnoea (hospitalization duration: 30 day(s)). The patient underwent the following laboratory tests and procedures: Body height: 5 foot 2. Therapeutic measures were taken as a result of tuberculosis, dyspnoea, illness.  Clinical course: Term highlighted by the reporter: Yes, highlighted by the reporter, serious. There were no information for results in death, life threatening, disabling/incapacitating, congenital anomaly/birth defect, other medically important condition, caused/prolonged hospitalization: true. There were no other conditions, investigations, other products. Infected with tuberculosis: Is done with medication now, done with the treatment. Clarified that caller had treatment for tuberculosis. After first shot, she was sick and when she went for second shot, was sick so, they could not give her the second dose. After one week, went back to hospital and they found out she was infected with TB, tuberculosis and treatment started. Clarified that she did not get second dose Covid-19 vaccine. Clarified that she was admitted to hospital for one month. When she was there they found the tuberculosis. Went to hospital because of shortness of breath. When she went to the hospital, they tested her and found out she had active tuberculosis. Treatment: Just finished treatment this month, 05Jan2023. Name of treatment was unknown. Was taking a medication from the Clinic. NDC, LOT, EXP: Unknown. Not able to read vaccine card, it is messy. Clarified that she only had one dose of Covid-19 vaccine. There was prior vaccinations (within 4 weeks) and family medical history relevant to adverse events (AEs). Seriousness Criteria: hospitalization, if hospitalized, duration of stay: 1 month. AE required visit to: check all that apply: Hospital admission 1 month. Autopsy Information: N/A.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
pt recv 2 doses of vax OCT95 & NOV95;APR96 pt failed to develop antibodies;23MAY96 Md was exposed to chicken pox;
This spontaneous report as received from a healthcare worker refers to an unspecified number of patients of unknown age and gender. Information regarding medical history and drug reactions or allergies was not reported. In approximately 2014 (exact dates not reported) unspecified number of patients were vaccinated with ZOSTAVAX, (subdermal, dose, anatomical location, lot#, expiration date not reported) that had been improperly exposed to -9 Celsius degrees since 01-MAY-2014. Concomitant medications were not reported. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Headache, CoughWheeze, NauseaVomiting, Syncope, Congestion, Left arm pain Narrative:  Other Relevant History:
epistaxis began 9hr p/vax;took 45min to stop;sl nose bleeds next 7-14 days;
redness, swelling aprox 2 inches, lump at site, itching with no rash on upper and lower back and legs starting on 8/22 as of 8/28 site reaction is resolved but still has mild itching
On 09/21/2022 I was having pain in my head, fever and fatigue. Lasted about 2 to three days.  pain and fatigue comes and goes periodically.
This spontaneous report as received from a registered nurse refers to unspecified number of patients of unknown age and gender. The patients' medical history, concurrent conditions and concomitant medications were not reported. On unknown dates, the patients were vaccinated with the improperly stored doses of PROQUAD (lot # L030591 with expiration date 10-FEB-2017, lot # L041629 with expiration date 22-APR-2017 and lot # L046507 with expiration date 17-MAY-2017; dose and route of administration were not reported). No adverse effects were reported. The call was made because of the data logger. PROQUAD (Merck) with lot # L030591 was stored in 7.6 degrees of Celsius for 49 hours. PROQUAD (Merck) with lot # L041629 and with lot # L046507 were stored in -12.2 degrees of Celsius for 1 hour. This is one of several reports received from the same reporter. Additional information is not expected as the reporter did not wish to be contacted.
Patient requested Bi-valent and was given Mono-valent.  Patient was advised that she will be eligible to return for the bi-valent vaccine in two months.
Seizure,numbness on whole right side,back pain, face droop,extreme fatigue,dizziness,headache,pain in shoulder